Tiziana Life Sciences (TILS)
TILS Share PerformanceMore
|52 week high||210.00 08/06/17|
|52 week low||55.00 23/05/18|
|52 week change||-116.00 (-61.05%)|
|4 week volume||377,333 28/04/18|
Latest News« previous» nextMore
23/05/2018 - 16:40 RNS
RNS Number: 0882P Tiziana Life Sciences PLC 23 May 2018 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined...
23/05/2018 - 16:35 RNS
RNS Number: 0876P Tiziana Life Sciences PLC 23 May 2018 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the executi...
16/05/2018 - 09:31 StockMarketWire
Tiziana Life Sciences, which is developing drugs targeting cancer and inflammatory diseases, said it had received a positive...
16/05/2018 - 07:00 RNS
RNS Number: 1999O Tiziana Life Sciences PLC 16 May 2018 Tiziana Life Sciences plc ("Tiziana" or the "Company") Tiziana Life Sciences Announces Interim Analysis Data from an Ongoing Phase 2a Trial of Milciclib Safety and Tolerability in Sorafenib-refractory or -intolerable, Unresectable or Metastatic Hepatocellular Carcinoma (HCC) Patients Treatment with ...
01/05/2018 - 15:00 RNS
RNS Number: 7744M Tiziana Life Sciences PLC 01 May 2018 Tiziana Life Sciences PLC ("Tiziana" or the "Company") Grant of options - Director's dealing London, 1 May 2018 - Tiziana Life Sciences plc (AIM: TILS), the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces that the remuneration com...
27/04/2018 - 07:00 RNS
RNS Number: 3188M Tiziana Life Sciences PLC 27 April 2018 Tiziana Life Sciences plc (" Tiziana " or the " Company ") Issue of equity 27 April 2018 Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases, today announces that it has allotted 23,014 ordinary shares in the Company a...
19/04/2018 - 08:05 StockMarketWire
Tiziana Life Sciences, a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune disea...
19/04/2018 - 07:00 RNS
RNS Number: 3791L Tiziana Life Sciences PLC 19 April 2018 Tiziana Life Sciences plc (" Tiziana " or the " Company ") Subscription raising 825,000 London, April 19, 2018 - Tiziana Life Sciences plc ("Tiziana", AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases, today announces that it has raised 825,000 i...
|Dividend yield||0 %|
Latest discussion posts More
“Back to reality during the day but closes @ 147.5 up 50.5%. If only!”▼
“Just opened my Barclays portfolio, Tils up 54.4% to 147.5. I wish. Back down to earth with a thump”▼
“Don't panic, Don't panic Totally misread that sale 10000 shares total #11200”▼
Codes & Symbols
|Symbols||TILS, LSE:TILS, TILS.L, TILS:LN, LON:TILS, XLON:TILS|